Showing results (491-500 of 588) with videos related to

Sort By:
Pageof 59
Archives of Internal Medicine|May 23, 1994
Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control studyC L Celum, R W Coombs, M Jones, et al.
The Journal of Infectious Diseases|July 4, 1998
Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccineR L Ashley, F M Crisostomo, M Doss, et al.
The New England Journal of Medicine|June 14, 1984
A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infectionJ M Douglas, C Critchlow, J Benedetti, et al.
Sexually Transmitted Diseases|July 1, 1993
Underestimation of HSV-2 seroprevalence in a high-risk population by microneutralization assayR L Ashley, J Dalessio, J Dragavon, et al.
Archives of General Psychiatry|October 1, 1992
Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research ProgramM T Shea, I Elkin, S D Imber, et al.
The American Journal of Psychiatry|August 1, 1991
Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research ProgramS M Sotsky, D R Glass, M T Shea, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 30, 2016
Preparation, Structure, and Reactivity of Pseudocyclic Benziodoxole Tosylates: New Hypervalent Iodine Oxidants and ElectrophilesAkira Yoshimura, Scott C Klasen, Michael T Shea, et al.
The Journal of Infectious Diseases|February 1, 1997
Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupW B Paxton, R W Coombs, M J McElrath, et al.
Blood|February 26, 2000
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonalityH Soudeyns, G Campi, G P Rizzardi, et al.
The Journal of Infectious Diseases|December 1, 1993
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group NetworkR B Belshe, M L Clements, R Dolin, et al.
Pageof 59